Alzheimer’s drug approved in the UK, but it won’t be available on the NHS—here’s why

The UK’s drugs regulator—the MHRA—has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.

Digital mental health programs are inexpensive and innovative. But do they work?
Almost half of Australians will experience mental health problems in their lifetime. Recent floods, droughts, cyclones, bushfires and the COVID pandemic have increased distress in the community.
How often should I wash my exercise clothes?
When you come home from a run or a sweaty gym session, do you immediately fling your clothes into the washing machine for a hot cycle? Or do you leave them on a chair (or the floordrobe) so you can wear them again tomorrow?
An artificial heart may save your life. But it can also change you in surprising ways
This week, doctors announced that an Australian man with severe heart failure had left hospital with an artificial heart that had kept him alive until he could receive a donor heart.
Deep learning uncovers gene targets and potential drugs to slow brain aging
In a new study reported in Science Advances, scientists analyzed MRI data stored at the UK Biobank and identified seven genes responsible for fast biological brain aging and 13 existing drugs that can target those genes.
Latin American researchers denounce economic and cultural inequities in the global scientific publishing system
Researchers from Brazilian, Argentine, and Uruguayan institutions analyze the barriers that low- and middle-income countries face in disseminating research on intensive care medicine, particularly in the treatment of critically ill patients.